FindTrial
Sign In

Genetics and pharmacogenetics study based on primarily cultured human umbilical vein endothelial cells

Genetics and pharmacogenetics study based on primarily cultured human umbilical vein endothelial cells

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR-OCS-12002819
Enrollment
Unknown
Registered
2012-12-19
Start date
2009-09-02
Completion date
Unknown
Last updated
2017-04-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Interventions

1:Angiotensin II and 4-HNE

Sponsors

School of Pharmacentical Sciences, Central South University
Lead Sponsor

Eligibility

Sex/Gender
Female
Age
20 Years to 50 Years

Inclusion criteria

Inclusion criteria: healthy pregnant women without smoking and drinking history

Exclusion criteria

Exclusion criteria: unhealthy pregnant women

Design outcomes

Primary

MeasureTime frame
mRNA and protein expression;—

Countries

China

Contacts

Public ContactXiao-Ping Chen
chenxp74@hotmail.com+86 13875803018

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026